Beam Therapeutics Inc. · NASDAQ:BEAM
State Street Corp reported a 5.20% stake in Beam Therapeutics Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 9, 2026
State Street Corp reported a 5.20% stake in Beam Therapeutics Inc., 5,228,529 shares, as a passive investor on Dec 31, 2025. Filed Feb 9, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 5,228,529
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.20% | 5,228,529 |
Source
Related
- Beam Therapeutics Inc.
- State Street Corp
- Beam Therapeutics Inc. shareholders
- Form 4 · Evans John M. · Oct 16, 2026
- Form 4 · Cavanagh Bethany J · Oct 2, 2026
- Form 4 · Ciaramella Giuseppe · Sep 25, 2026
- Schedule 13G/A · ARK Investment Management LLC · Aug 14, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026